Manejo de antibióticos en pacientes resistentes a los betalactamicos
Date
2018-02-09
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Inca Garcilaso de la Vega
Abstract
Los betalactámicos son los antibióticos más indicados en la atención primaria que hoy en día es un problema a nivel mundial debido al uso indiscriminado o prolongado de los betalactámicos que son la causa principal del incremento de la resistencia bacteriana. Ante esta problemática el uso de estos fármacos debería estar restringido y su prescripción debe ser ene caso que sea realmente necesarios y cuando el beneficio sea más que el riesgo de su efectividad, los profesionales odontólogos deben saber que los betalactámicos no son efectivos en el tratamiento de enfermedades crónicas, en la mayoría de los casos su uso es para un tratamiento a corto plazo de las enfermedades infecciosas con síntomas agudos o como medida profiláctica
Betalactamics are the most indicated antibiotics in primary care that today is a worldwide problema due to the indiscriminate or prolonged use of betalactamics that are the main cause of the increase in baseline resistance. Faced with this problem, the use of these drugs should be restricted and their prescription should be in case that are really necessary and when the benefit is more than the risk of their effectiveness, dentists should know that betalactamics are not effective in the treatment of chronic diseases, in most cases its use is for a short- term treatment of infectious diseases with acute symptoms or as a prophylactic measure.
Betalactamics are the most indicated antibiotics in primary care that today is a worldwide problema due to the indiscriminate or prolonged use of betalactamics that are the main cause of the increase in baseline resistance. Faced with this problem, the use of these drugs should be restricted and their prescription should be in case that are really necessary and when the benefit is more than the risk of their effectiveness, dentists should know that betalactamics are not effective in the treatment of chronic diseases, in most cases its use is for a short- term treatment of infectious diseases with acute symptoms or as a prophylactic measure.
Description
Keywords
Betalactamasa, Celulitis, Bactericida, Sistémico, Anaerobio, Betalactamase, Cellulitis, Bactericide, Systemic, Anaerobic